The Nasdaq Composite dropped by around 150 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision. Below is a look at a few recent notable insider sales. For more, check out Benzinga''s insider transactions platform. Nu Skin Enterprises The Trade: Nu Skin Enterprises, Inc. (NYSE: NUS ) Director Andrew D Lipman sold a total of 1,000 shares at an average price of $36.67. The insider … Full story available on Benzinga.com
Nu Skin Enterprises with ticker code (NUS) have now 4 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 52 and 40 calculating the mean target price we have 47. Now with the previous closing price of 36.97 this would imply there is a potential upside of 27.1%. The 50 day MA is 42.18 and the 200 moving average now moves to 46.25. The market cap for the company is $1,857m. Find out more information at: https://www.nuskin.com [stock_market_widget type="chart" template="basic" color="green" assets="NUS" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $2,360m based on the market concensus. Nu Skin Enterprises develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.
Nu Skin Enterprises with ticker code (NUS) have now 4 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 52 and 40 and has a mean target at 47. With the stocks previous close at 39.54 this indicates there is a potential upside of 18.9%. The day 50 moving average is 43.34 and the 200 day moving average is 46.64. The company has a market cap of $1,981m. You can visit the company''s website by visiting: https://www.nuskin.com [stock_market_widget type="chart" template="basic" color="green" assets="NUS" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $2,355m based on the market concensus. Nu Skin Enterprises develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.
Nu Skin Enterprises found using ticker (NUS) now have 4 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 52 and 40 with a mean TP of 47. Given that the stocks previous close was at 42.32 this indicates there is a potential upside of 11.1%. The 50 day MA is 43.97 and the 200 day moving average is 46.82. The market capitalisation for the company is $2,188m. Find out more information at: https://www.nuskin.com [stock_market_widget type="chart" template="basic" color="green" assets="NUS" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $2,429m based on the market concensus. Nu Skin Enterprises develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.
According to Benzinga Pro, during Q2, Nu Skin Enterprises (NYSE: NUS ) earned $34.24 million, a 11.57% increase from the preceding quarter. Nu Skin Enterprises''s sales decreased to $560.62 million, a 7.32% change since Q1. Nu Skin Enterprises earned $38.72 million, and sales totaled $604.90 million in Q1. What Is ROCE? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of successful growth of a company … Full story available on Benzinga.com
Nu Skin Enterprises with ticker code (NUS) have now 5 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 55 and 45 calculating the average target price we see 49.2. Now with the previous closing price of 44.87 this would indicate that there is a potential upside of 9.7%. There is a 50 day moving average of 44.28 and the 200 moving average now moves to 46.55. The company has a market cap of $2,239m. You can visit the company''s website by visiting: https://www.nuskin.com [stock_market_widget type="chart" template="basic" color="green" assets="NUS" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $2,455m based on the market concensus. Nu Skin Enterprises develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.
Nu Skin Enterprises, Inc. (NYSE:NYSE:NUS) Q2 2022 Earnings Conference Call August 04, 2022 05:00 PM ET Company Participants Scott Pond - Vice President of Investor Relations Ryan Napierski…
The following slide deck was published by Nu Skin Enterprises, Inc.
Nu Skin press release (NUS): Q2 GAAP EPS of $0.67 misses by $0.10.Revenue of $560.6M (-20.4% Y/Y) misses by $30.38M.Q3 2022 outlook Revenue:$550 to $590 million.Q3 2022 outlook…
PROVO, Utah, Aug. 4, 2022 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second quarter 2022 results. Executive Summary Q2 2022 vs. Prior-year Quarter Revenue: $560.6 million; (20)% (5)% FX impact or $(34.6) million Earnings Per Share (EPS): $0.67 or $0.77 excluding…
Nu Skin (NUS) is scheduled to announce Q2 earnings results on Thursday, August 4th, after market close.The consensus EPS Estimate is $0.75 and the consensus Revenue Estimate is…
Nu Skin Enterprises, Inc . NUS is likely to display year-over-year declines in the top and bottom lines when it reports second-quarter 2022 earnings on Aug 4. The Zacks Consensus Estimate for revenues is pegged at $559.9 million, suggesting a decline of 20.5% from the prior-year quarter''s reported figure. Although the Zacks Consensus Estimate for earnings has moved 6.8% north over the past 30 days to 79 cents per share, it indicates a decrease of 31.3% from the figure reported in the prior-year period. In the last reported quarter, the company delivered an earnings surprise of 4.1%. The developer and distributor of personal care and wellness products has a trailing four-quarter earnings surprise of 10.6%, on average. Key Factors to Note In a recent release, Nu Skin stated that second-quarter revenues bore the brunt of global uncertainties like continued COVID-related headwinds in Mainland China, challenges in EMEA related to the ongoing conflict between Russia and Ukraine, and the global economic downturn in regions like Latin America.
Nu Skin Enterprises with ticker code (NUS) have now 5 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 55 and 45 and has a mean target at 49.2. With the stocks previous close at 43.36 this would imply there is a potential upside of 13.5%. The day 50 moving average is 44.37 and the 200 day moving average is 46.46. The market capitalisation for the company is $2,218m. Find out more information at: https://www.nuskin.com [stock_market_widget type="chart" template="basic" color="green" assets="NUS" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $2,517m based on the market concensus. Nu Skin Enterprises develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.
Nu Skin Enterprises with ticker code (NUS) now have 5 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 55 and 45 calculating the average target price we see 50. Given that the stocks previous close was at 42.62 this now indicates there is a potential upside of 17.3%. The 50 day moving average now sits at 44.55 and the 200 moving average now moves to 46.4. The market capitalisation for the company is $2,156m. Company Website: https://www.nuskin.com [stock_market_widget type="chart" template="basic" color="green" assets="NUS" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $2,529m based on the market concensus. Nu Skin Enterprises develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.
Stocks that traded heavily or had substantial price changes Friday: Levi, Costco rise; Nu Skin, WD-40 fall
Nu Skin Enterprises (NUS) on Thursday cut its Q2 revenue guidance, citing COVID-19-related disruptions in China, the Ukraine war and macro headwinds.NUS expects to report Q2 revenue…
US crude oil futures traded lower on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision. Below is a look at a few recent notable insider sales. For more, check out Benzinga''s insider transactions platform. Nu Skin Enterprises The Trade: Nu Skin Enterprises, Inc. (NYSE: NUS ) Director, Exec. Chairman of the Board Steven Lund sold a total of 8,126 shares at … Full story available on Benzinga.com
PROVO, Utah , June 7, 2022 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS ) today announced President and CEO Ryan Napierski and Chief Financial Officer Mark Lawrence will present at the Stifel Cross Sector Insight Conference on Thursday, June 9, 2022. They will participate in a fireside chat to discuss the company''s Nu Vision 2025 strategy as well as opportunities and trends in the beauty and wellness space.
The trading price of Nu Skin Enterprises Inc. (NYSE:NUS) closed higher on Friday, May 27, closing at $46.11, 1.61% higher than its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << Traders who pay close attention to intraday price movement should know that it fluctuated between … Nu Skin Enterprises Inc.’s (NYSE: NUS) Stock Forecast: Increase To $60.00 In A Year Read More »
Nu Skin Enterprises with ticker code (NUS) now have 5 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 60 and 45 with the average target price sitting at 51.6. With the stocks previous close at 45.34 this would indicate that there is a potential upside of 13.8%. The 50 day moving average now sits at 46.49 and the 200 moving average now moves to 47.13. The market cap for the company is $2,209m. Find out more information at: https://www.nuskin.com [stock_market_widget type="chart" template="basic" color="green" assets="NUS" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $2,514m based on the market concensus. Nu Skin Enterprises develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.
The report titled Global Smart Beauty Devices Market is one of the most comprehensive and important additions to QY Researchs archive of market research studies. It offers detailed research and analysis of key aspects of the global Smart Beauty Devices market. The market analysts authoring this report have provided in-depth information on leading growth []
Global Halal Bodywash Market highlights the information about the dominant players industries and market, technologies, and abilities over the trends and the developments of the industries. After deep research and analysis by the experts, they also disclosed the data about the strong contenders contributing in the market growth and expansion and challenging one another in []
PROVO, Utah, July 7, 2021 /PRNewswire/ -- Nu Skin (NYSE: NUS) is hosting its annual Force for Good Day as part of its commitment to humanitarian efforts both locally and globally. It is a day set aside for Nu Skin brand affiliates, employees and their families to participate in local
PROVO, Utah, July 6, 2021 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release second-quarter results after the market closes on Wednesday, Aug. 4. The Nu Skin management team will host a conference call with the investment community later that same day at
Nu Skin Enterprises found using ticker (NUS) now have 6 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 80 and 60 with the average target price sitting at 66.67. Given that the stocks previous close was at 56.65 this would imply there is a potential upside of 17.7%. There is a 50 day moving average of 59.35 while the 200 day moving average is 55.45. The market cap for the company is $2,835m. Company Website: /> [stock_market_widget type="chart" symbol="NUS" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Nu Skin Enterprises develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products.
PT Indika Energy Tbk (INDY) bakal mengakuisisi tambang emas milik Nusantara Resources Limited (Nusantara).
→ Google Translate
Nu Skin Enterprises, Inc. NUS looks solid, courtesy of focus on strategic growth efforts like innovation, as well as efforts to strengthen sales leaders and expand the customer base. Notably, this Zacks Rank #2 (Buy) stock has surged 48.6% in the past year compared with the industrys growth of 45.6%. The stock has comfortably outperformed [] The post Nu Skin (NUS) Looks Promising: Stock Up More Than 45% in a Year appeared first on UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News .
Nu Skin Enterprises found using ticker (NUS) have now 6 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 80 and 60 calculating the average target price we see 66. With the stocks previous close at 58.62 this indicates there is a potential upside of 12.6%. The day 50 moving average is 58.88 and the 200 day moving average is 55.04. The market cap for the company is $2,933m. Company Website: /> [stock_market_widget type="chart" symbol="NUS" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Nu Skin Enterprises develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products.
PROVO, Utah, June 17, 2021 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced announced President and CEO-elect Ryan Napierski and Chief Financial Officer Mark Lawrence will present at the Jefferies Virtual Consumer Conference on Tuesday, June 22, 2021. They will be
Nu Skin Enterprises with ticker code (NUS) have now 6 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 80 and 60 calculating the mean target price we have 66. Given that the stocks previous close was at 62.44 this would indicate that there is a potential upside of 5.7%. There is a 50 day moving average of 58.01 and the 200 moving average now moves to 54.78. The market cap for the company is $3,046m. Visit the company website at: /> [stock_market_widget type="chart" symbol="NUS" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Nu Skin Enterprises develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products.
A Relative Strength Rating upgrade for Nu Skin Enterprises Inc shows improving technical performance. Will it continue?
The Market Abstract of Facial Cleansing Devices Market The Facial Cleansing Devices market report is designed to include both qualitative and quantitative aspects of the business in globally each region and country participating in the study. The report also offers detailed
Related Stocks: NUS ,
Nu Skin Enterprises found using ticker (NUS) have now 6 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 80 and 60 calculating the average target price we see 66. With the stocks previous close at 60.82 this now indicates there is a potential upside of 8.5%. The 50 day MA is 56.88 while the 200 day moving average is 54.42. The market cap for the company is $3,022m. Find out more information at: /> [stock_market_widget type="chart" symbol="NUS" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Nu Skin Enterprises develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products.
PROVO, Utah, June 2, 2021 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the addition of two new members to serve on its Board of Directors. Shareholders earlier today elected Ryan S. Napierski, Nu Skin''s president and CEO-elect, and Emma S. Battle, founder and CEO
The multivitamin tablets & capsules market has witnessed significant growth due to rise in the demand for supplement products as vitamins are essential for fitness. Moreover, increased consumption of multivitamin capsules & tablets. provides a huge market opportunity for the key players operating in the multivitamin tablets & capsules market. However, strict government regulations is projected to1 Posted via Industry Today. Follow us on Twitter @IndustryToday
https://www.investing.com/analysis/nu-skin-nus-looks-buoyant-on-product-launches--online-sales-200582981
Nu Skin Enterprises found using ticker (NUS) have now 6 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 80 and 60 with a mean TP of 66. Now with the previous closing price of 59.91 this would indicate that there is a potential upside of 10.2%. The 50 day moving average now sits at 55.81 and the 200 day moving average is 54.08. The market capitalisation for the company is $3,034m. Company Website: /> [stock_market_widget type="chart" symbol="NUS" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Nu Skin Enterprises develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products.
Nu Skin Enterprises found using ticker (NUS) now have 6 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 80 and 60 with a mean TP of 66. Given that the stocks previous close was at 58.91 this would indicate that there is a potential upside of 12.0%. The 50 day moving average now sits at 54.77 and the 200 day MA is 53.81. The company has a market capitalisation of $3,006m. Company Website: /> [stock_market_widget type="chart" symbol="NUS" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Nu Skin Enterprises develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products.
Jefferies Stick to Their Buy Rating for Nu Skin Enterprises
PROVO, Utah, March 23, 2021 /PRNewswire/ -- Nu Skin, a global leader in innovative beauty and wellness products powered by its dynamic business opportunity platform, has been ranked the world's number one brand for beauty device systems for four consecutive years by Euromonitor…
Nu Skin Enterprises (NYSE:NUS) announced its earnings results on Thursday. The company reported $1.40 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.19 by $0.21, MarketWatch Earnings reports. Nu Skin Enterprises had a net margin of 6.54% and a return on equity of 19.18%. NYSE NUS traded down $9.22 on Thursday, reaching […]
Beauty and wellness solutions provider Nu Skin’s fourth-quarter diluted earnings per share (EPS) surged 94% to $1.40 year-on-year, beating the Street consensus of … The post Nu Skin’s 4Q Profit Jumps 94% appeared first on Smarter Analyst .
PROVO, Utah, Feb. 10, 2021 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced fourth-quarter 2020 results, achieving 28 percent revenue growth and 94 percent earnings per share (EPS) growth. For the full year, revenue increased seven percent and EPS increased 17 percent….
PROVO, Utah, Feb. 10, 2021 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced Ryan Napierski, the company's president, has been selected by the Nu Skin Board of Directors to become the company's next president and chief executive officer. Napierski will succeed Nu Skin…
PROVO, Utah, Feb. 10, 2021 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced its board of directors has increased the quarterly cash dividend to $0.38 per share, which will be paid on March 10, 2021, to shareholders of record on Feb. 26, 2021. "This marks our 20th…
PROVO, Utah, Feb. 9, 2021 /PRNewswire/ -- Nu Skin, a global leader in premium-quality beauty and wellness products, today announced it is the first beauty brand to use sugarcane-based Eco-Pac sustainable packaging. With this refresh, Epoch, which is celebrating its 25th anniversary, is…
Nu Skin Enterprises, Inc. (NYSE:NUS) President Ryan S. Napierski sold 10,156 shares of the business’s stock in a transaction that occurred on Wednesday, January 20th. The stock was sold at an average price of $59.12, for a total transaction of $600,422.72. Following the completion of the transaction, the president now owns 83,656 shares of the […]
PROVO, Utah, Jan. 6, 2021 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will hold a virtual investor day event on Feb. 11 at noon (ET). Registrants can expect to hear from senior management as they share the company outlook for 2021 along with longer-term…
PROVO, Utah, Dec. 17, 2020 /PRNewswire/ -- Nu Skin was recognized with multiple awards by the U.S. Direct Selling Association (DSA) this week at the 2020 DSA Virtual Awards Ceremony. The company's sustainability efforts won in the Vision for Tomorrow category, and its Velocity sales…